Patent applications and USPTO patent grants for Bausch Health Ireland, Limited.The latest application filed is for "methods of using rifamycin sv for the treatment of sickle cell disease".
Patent | Date |
---|---|
Methods Of Using Rifamycin Sv For The Treatment Of Sickle Cell Disease App 20220280478 - Lowe; Ezra R. ;   et al. | 2022-09-08 |
Encrypted memory device Grant 11,403,386 - Fix , et al. August 2, 2 | 2022-08-02 |
Access device Grant D959,428 - Bockenstedt , et al. August 2, 2 | 2022-08-02 |
Light therapy device Grant D959,004 - Bockenstedt , et al. July 26, 2 | 2022-07-26 |
Light therapy device Grant D959,003 - Bockenstedt , et al. July 26, 2 | 2022-07-26 |
Methods and apparatus for pumping coolant to an energy delivery device Grant 11,395,692 - Bockenstedt , et al. July 26, 2 | 2022-07-26 |
Topical Pharmaceutical Compositions For Treating Skin Conditions App 20220226271 - Bhatt; Varsha ;   et al. | 2022-07-21 |
Topical compositions Grant 11,389,467 - Bhatt , et al. July 19, 2 | 2022-07-19 |
Redundant Traces For Flexible Circuits Used In An Energy Delivery Device App 20220219005 - Collins; Craig ;   et al. | 2022-07-14 |
Polymeric emulsion delivery systems Grant 11,364,198 - Angel , et al. June 21, 2 | 2022-06-21 |
Use Of Methylnaltrexone And Rifaximin For Treatment Of Increased Gut Permeability Or Associated Disorders App 20220175764 - Johnson; Lorin K. ;   et al. | 2022-06-09 |
Topical pharmaceutical compositions for treating skin conditions Grant 11,324,710 - Bhatt , et al. May 10, 2 | 2022-05-10 |
Ultra-pure agonists of guanylate cyclase C, method of making and using same Grant 11,319,346 - Shailubhai , et al. May 3, 2 | 2022-05-03 |
Ultra-pure Agonists Of Guanylate Cyclase C, Method Of Making And Using Same App 20220119449 - Shailubhai; Kunwar ;   et al. | 2022-04-21 |
Liquid Oral Dosage Formulations Of Methylnaltrexone App 20220096461 - Rohrs; Brian R. ;   et al. | 2022-03-31 |
Redundant traces for flexible circuits used in an energy delivery device Grant 11,273,316 - Collins , et al. March 15, 2 | 2022-03-15 |
Ceramic Applicator For Transcutaneous Delivery Of Energy App 20220022937 - Bennett; Frederick Jay ;   et al. | 2022-01-27 |
Microblade Structure And Method Of Treating Tissue App 20220015818 - Bennett; Frederick Jay ;   et al. | 2022-01-20 |
Compositions and methods for treating diseases of the nail Grant 11,213,519 - Winckle , et al. January 4, 2 | 2022-01-04 |
Access device Grant D940,133 - Bockenstedt , et al. January 4, 2 | 2022-01-04 |
Pharmaceutical formulations containing corticosteroids for topical administration Grant 11,213,587 - Angel , et al. January 4, 2 | 2022-01-04 |
Ultra-pure Agonists Of Guanylate Cyclase C, Method Of Making And Using Same App 20210403508 - Shailubhai; Kunwar ;   et al. | 2021-12-30 |
Agonists Of Guanylate Cyclase And Their Uses App 20210379142 - RIFF; Dennis ;   et al. | 2021-12-09 |
Ultra-pure agonists of guanylate cyclase C, method of making and using same Grant 11,142,549 - Shailubhai , et al. October 12, 2 | 2021-10-12 |
Light therapy device Grant D928,975 - Bockenstedt , et al. August 24, 2 | 2021-08-24 |
Multidose package, course and method of treatment for delivering predetermined multiple doses of a pharmaceutical Grant 11,077,102 - Hutchings , et al. August 3, 2 | 2021-08-03 |
Stabilized Efinaconazole Compositions App 20210205457 - Bhatt; Varsha ;   et al. | 2021-07-08 |
Formulations Of Guanylate Cyclase C Agonists And Methods Of Use App 20210205406 - Comiskey; Stephen ;   et al. | 2021-07-08 |
Light therapy device Grant D922,595 - Bockenstedt , et al. June 15, 2 | 2021-06-15 |
Light therapy device Grant D921,212 - Bockenstedt , et al. June 1, 2 | 2021-06-01 |
Agonists of guanylate cyclase and their uses Grant 10,967,043 - Riff , et al. April 6, 2 | 2021-04-06 |
Grafted Polymer And Use Thereof App 20210087384 - DiBella, JR.; James Anthony ;   et al. | 2021-03-25 |
Methods for manufacturing phenoxyethanol Grant 10,941,097 - March 9, 2 | 2021-03-09 |
Topical Compositions App 20210030778 - BHATT; Varsha ;   et al. | 2021-02-04 |
Ultra-pure Agonists Of Guanylate Cyclase C, Method Of Making And Using Same App 20200399315 - Shailubhai; Kunwar ;   et al. | 2020-12-24 |
Stabilized efinaconazole formulations Grant 10,864,274 - Bhatt , et al. December 15, 2 | 2020-12-15 |
Formulations Of Guanylate Cyclase C Agonists And Methods Of Use App 20200384068 - Comiskey; Stephen ;   et al. | 2020-12-10 |
Agonists Of Guanylate Cyclase Useful For The Treatment Of Opioid Induced Dysfunctions App 20200330548 - SHAILUBHAI; Kunwar ;   et al. | 2020-10-22 |
Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis App 20200325176 - Shailubhai; Kunwar ;   et al. | 2020-10-15 |
Formulations And Methods For Treating Ulcerative Colitis App 20200316164 - SHAILUBHAI; Kunwar ;   et al. | 2020-10-08 |
Topical Compositions And Methods For Treating Acne Vulgaris App 20200297684 - Pillai; Radhakrishnan ;   et al. | 2020-09-24 |
Agonists Of Guanylate Cyclase Useful For The Treatment Of Gastrointestinal Disorders, Inflammation, Cancer And Other Disorders App 20200283480 - SHAILUBHAI; KUNWAR ;   et al. | 2020-09-10 |
Ultra-pure agonists of guanylate cyclase C, method of making and using same Grant 10,745,441 - Shailubhai , et al. A | 2020-08-18 |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders Grant 10,711,038 - Shailubhai , et al. | 2020-07-14 |
Methods for manufacturing phenoxyethanol App 20200199057 - Dabrowska-Mas; Elzbieta ;   et al. | 2020-06-25 |
Formulations and methods for treating ulcerative colitis Grant 10,653,744 - Shailubhai , et al. | 2020-05-19 |
Topical pharmaceutical compositions for treating skin conditions Grant 10,653,656 - Bhatt , et al. | 2020-05-19 |
Agonists Of Guanylate Cyclase Useful For Downregulation Of Pro-inflammatory Cytokines App 20200113968 - Shailubhai; Kunwar | 2020-04-16 |
Agonists of guanylate cyclase and their uses Grant 10,597,424 - Shailubhai | 2020-03-24 |
Pain Mitigation By Mechanical Stimulation When Treating Tissue With Electromagnetic Energy App 20200069356 - Bockenstedt; Craig Robert ;   et al. | 2020-03-05 |
Redundant Traces For Flexible Circuits Used In An Energy Delivery Device App 20200069955 - Collins; Craig ;   et al. | 2020-03-05 |
Encrypted Memory Device App 20200074068 - Fix; Richard L. ;   et al. | 2020-03-05 |
Methods And Apparatus For Pumping Coolant To An Energy Delivery Device App 20200069354 - Bockenstedt; Craig Robert ;   et al. | 2020-03-05 |
Agonists Of Guanylate Cyclase And Their Uses App 20200054709 - RIFF; Dennis ;   et al. | 2020-02-20 |
Process of Preparing Guanylate Cyclase C Agonists App 20200040038 - Bai; Juncai ;   et al. | 2020-02-06 |
Compositions And Method For The Treatment And Detection Of Colon Cancer App 20200023080 - SHAILUBHAI; Kunwar ;   et al. | 2020-01-23 |
Agonists Of Guanylate Cyclase Useful For The Treatment Of Opioid Induced Dysfunctions App 20200009215 - SHAILUBHAI; Kunwar ;   et al. | 2020-01-09 |
Formulations Of Guanylate Cyclase C Agonists And Methods Of Use App 20200009063 - SHAILUBHAI; Kunwar ;   et al. | 2020-01-09 |
Stabilized Efinaconazole Formulations App 20190358329 - Bhatt; Varsha ;   et al. | 2019-11-28 |
Multidose Package, Course And Method Of Treatment For Delivering Predetermined Multiple Doses Of A Pharmaceutical App 20190350924 - HUTCHINGS; MARK J. ;   et al. | 2019-11-21 |
Formulations Of Guanylate Cyclase C Agonists And Methods Of Use App 20190321439 - Comiskey; Stephen ;   et al. | 2019-10-24 |
Topical Pharmaceutical Compositions For Treating Skin Conditions App 20190307717 - Bhatt; Varsha ;   et al. | 2019-10-10 |
Polymeric Emulsion Delivery Systems App 20190307682 - Angel; Arturo ;   et al. | 2019-10-10 |
Process of preparing guanylate cyclase C agonisys Grant 10,421,787 - Bai , et al. Sept | 2019-09-24 |
Agonists of guanylate cyclase and their uses Grant 10,342,848 - Riff , et al. July 9, 2 | 2019-07-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.